We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-3 of 3

Case comment: Glaxosmithkline Inc. (FCA) - elusive valuations of bundled transactions: defining a standard of reasonableness in transfer pricing
  • Gowling WLG
  • Canada
  • August 4 2010

The task of making valuations for transfer pricing involving bundled transactions has always been a daunting one.

Colleen McMullin
  • Gowling WLG